1429 related articles for article (PubMed ID: 8446617)
1. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
Strittmatter WJ; Saunders AM; Schmechel D; Pericak-Vance M; Enghild J; Salvesen GS; Roses AD
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1977-81. PubMed ID: 8446617
[TBL] [Abstract][Full Text] [Related]
2. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.
Strittmatter WJ; Weisgraber KH; Huang DY; Dong LM; Salvesen GS; Pericak-Vance M; Schmechel D; Saunders AM; Goldgaber D; Roses AD
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8098-102. PubMed ID: 8367470
[TBL] [Abstract][Full Text] [Related]
3. [Lipoproteins in clinical laboratory medicine].
Kuriyama M
Rinsho Byori; 1998 Dec; 46(12):1219-25. PubMed ID: 9916507
[TBL] [Abstract][Full Text] [Related]
4. [Apolipoprotein E4 and late-onset Alzheimer's disease].
Tamaoka A
Nihon Rinsho; 1994 Dec; 52(12):3257-65. PubMed ID: 7853720
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E polymorphism and Alzheimer's disease.
Poirier J; Davignon J; Bouthillier D; Kogan S; Bertrand P; Gauthier S
Lancet; 1993 Sep; 342(8873):697-9. PubMed ID: 8103819
[TBL] [Abstract][Full Text] [Related]
6. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E and Alzheimer disease.
Strittmatter WJ; Roses AD
Proc Natl Acad Sci U S A; 1995 May; 92(11):4725-7. PubMed ID: 7761390
[TBL] [Abstract][Full Text] [Related]
8. The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease.
Yu CE; Payami H; Olson JM; Boehnke M; Wijsman EM; Orr HT; Kukull WA; Goddard KA; Nemens E; White JA
Am J Hum Genet; 1994 Apr; 54(4):631-42. PubMed ID: 8128960
[TBL] [Abstract][Full Text] [Related]
9. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.
Schmechel DE; Saunders AM; Strittmatter WJ; Crain BJ; Hulette CM; Joo SH; Pericak-Vance MA; Goldgaber D; Roses AD
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9649-53. PubMed ID: 8415756
[TBL] [Abstract][Full Text] [Related]
10. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
Corder EH; Saunders AM; Strittmatter WJ; Schmechel DE; Gaskell PC; Small GW; Roses AD; Haines JL; Pericak-Vance MA
Science; 1993 Aug; 261(5123):921-3. PubMed ID: 8346443
[TBL] [Abstract][Full Text] [Related]
11. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.
Saunders AM; Strittmatter WJ; Schmechel D; George-Hyslop PH; Pericak-Vance MA; Joo SH; Rosi BL; Gusella JF; Crapper-MacLachlan DR; Alberts MJ
Neurology; 1993 Aug; 43(8):1467-72. PubMed ID: 8350998
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer pathology of patients carrying apolipoprotein E epsilon 4 allele.
Heinonen O; Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Sorvari H; Kosunen O; Paljärvi L; Ryynänen M; Riekkinen PJ
Neurobiol Aging; 1995; 16(4):505-13. PubMed ID: 8544899
[TBL] [Abstract][Full Text] [Related]
13. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease.
Berr C; Hauw JJ; Delaère P; Duyckaerts C; Amouyel P
Neurosci Lett; 1994 Sep; 178(2):221-4. PubMed ID: 7824200
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation.
Ohm TG; Kirca M; Bohl J; Scharnagl H; Gross W; März W
Neuroscience; 1995 Jun; 66(3):583-7. PubMed ID: 7644022
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E4 and beta amyloid in senile plaques and cerebral blood vessels of aged rhesus monkeys.
Poduri A; Gearing M; Rebeck GW; Mirra SS; Tigges J; Hyman BT
Am J Pathol; 1994 Jun; 144(6):1183-7. PubMed ID: 8203459
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease.
Kamboh MI
Hum Biol; 1995 Apr; 67(2):195-215. PubMed ID: 7729825
[TBL] [Abstract][Full Text] [Related]
18. The effect of apolipoprotein E genotype on expression of an autosomal dominant schizophreniform disorder with progressive dementia and neurofibrillary tangles.
Tsuang D; Raskind MA; Leverenz J; Peskind ER; Schellenberg G; Bird TD
Biol Psychiatry; 1997 Jan; 41(2):191-5. PubMed ID: 9018389
[TBL] [Abstract][Full Text] [Related]
19. Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease.
Gearing M; Rebeck GW; Hyman BT; Tigges J; Mirra SS
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9382-6. PubMed ID: 7937774
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease.
Beffert U; Poirier J
Ann N Y Acad Sci; 1996 Jan; 777():166-74. PubMed ID: 8624080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
